期刊文献+

高水平血清HCMV IgM在低龄儿童原发性HCMV感染诊断中的作用

Diagnostic role of high HCMV IgM level in serum for HCMV primary infection
下载PDF
导出
摘要 目的:探讨血清人巨细胞病毒(HCMV)IgM水平在低龄儿童中诊断原发性HCMV感染的意义。方法收集临床诊断为HCMV感染的患儿血标本56例,年龄为0.5-1岁,采用全自动化学发光法分别定量检测血清HCMV IgG、IgM抗体水平,以及IgG亲和力指数。结果 HCMV IgG+患儿亲和力检测结果发现,其中IgM-/IgG+的5例患者都为高亲和力IgG,而IgM+/IgG+的42例患者中25例是低亲和力IgG,占59.5%。根据IgM定量检测结果进一步将此47例HCMV IgG+患儿由低至高分成5组,分别为IgM阴性组(〈30 AU/mL),30-100 AU/mL组,100-170 AU/mL组,170-240 AU/mL组以及大于240 AU/mL组。随着IgM抗体水平的增加,低亲和力样本所占比例呈增高趋势,经卡方检验,差异有统计学意义(χ2=12.72,P〈0.05)。结论在0.5-1岁婴儿中,HCMV IgM水平与HCMV原发感染呈正相关,临床同时参考IgM定量检测和HCMV IgG亲合力检测结果,将对0.5-1岁以内婴幼儿近期HCMV感染发生时间的判定起到有益的互补作用。先进行HCMV IgM定量检测,再进行阳性病例的IgG亲和力检测是低龄儿童原发HCMV感染实验室诊断的可行方案。 Objective To study the diagnostic role of human cytomegalovirus (HCMV) IgM level for HCMV primary infection in lower aged children. Methods 56 serum samples were collected from 0.5~1 years old new borns, who were clinically diagnosed as HCMV infection. HCMV IgM/IgG and IgG avidity were quantitatively detected by automatic CLIA. Results Among the HCMV IgG positive samples, 5 samples, which were IgM-/IgG+, showed high HCMV IgG avidities. In the remaining 42 samples, which were IgM+/IgG+, 25 samples (about 59.5%) showed low IgG avidities. Based on the HCMV IgM level, the samples were further divided into 5 groups:IgM negative group (240 AU/mL group. It was found that the percentage of HCMV IgG low avidity samples were increased with increases of IgM levels. The difference was statistically significant (χ2=12.72, P〈0.05). Conclusion High HCMV IgM level in serum are positively correlated to HCMV primary infection among newborns of 0.5~1 age. Quantitative IgM assay could be complimentary to diagnosis of primary HCMV infection in paralle with IgG avidity test. This data imply that quantitatively detection of HCMV IgM antibody followed by IgG avidity detection is practical proposal for laboratory diagnosis of HCMV primary infection in lower aged children.
出处 《分子诊断与治疗杂志》 2013年第6期394-397,共4页 Journal of Molecular Diagnostics and Therapy
关键词 人巨细胞病毒 IGM IGG IgG亲合力 原发性感染 Human cytomegalovirus IgM IgG IgG avidity Primary Infection
  • 相关文献

参考文献10

  • 1无,方峰.儿童巨细胞病毒性疾病诊断和防治的建议[J].中华儿科杂志,2012,50(4):290-292. 被引量:190
  • 2Gaytant M A, Rours G I, Steegers E A, et al. Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature[J]. Eur J Pediatr, 2003, 162(4): 248-253.
  • 3Gandhi M K, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments[J]. Lancet Infect Dis, 2004, 4(12): 725-738.
  • 4梁国平,郭树春.巨细胞病毒与先天畸形及新生儿疾病[J].国际儿科学杂志,1984,30(1):15-18. 被引量:5
  • 5Nigro G, Adler S P, La Torre R, et al. Passive immunization during pregnancy for congenital cytomegalovirus infection[J]. N Engl J Med, 2005, 353(13): 1350-1362.
  • 6Mendelson E, Aboudy Y, Smetana Z, et al. Laboratory assessment and diagnosis of congenital viral infections: Rubella, cytomegalovirus (CMV), varicella-zoster virus (VZV), herpes simplex virus (HSV), parvovirus Bl9 and human immunodeficiency virus.
  • 7De Paschale M, Agrappi C, Manco M T, et al. Positive predictive value of anti-HCMV IgM as an index of primary infection[J]. J Virol Methods, 2010,168(1-2): 121-125.
  • 8Dollard S C, Staras S A, Amin M M, et al. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity[J]. Clin Vaccine Immunol, 2011, 18(11): 1895-1899.
  • 9Hedman K, Rousseau S A. Measurement of avidity of specific IgG for verification of recent primary rubella[J]. J Med Virol, 1989,27(4): 288-292.
  • 10Revello M G, Gorini G, Gerna G. Clinical evaluation of a chemiluminescence immunoassay for determination of immnoglobulin G avidity to human Cytomegalovirus[J]. Clin Diagn Lab Immunol, 2004, 11(4): 801-805.

二级参考文献12

  • 1董永绥.继续深入进行巨细胞病毒感染的研究[J].中华儿科杂志,1995,33(1):3-4. 被引量:108
  • 2Demmler GJ. Cytomegalovirus// Feigin RD, Cherry JD, Demmler GJ, eds. Textbook of pediatric infectious diseases. 6lh ed. Philadelphia : Saunders, 2009 : 2022-2043.
  • 3Stehel EK, S6nehez PJ. Cytomegalovirus infection in the fetus and neonate. Neoreviews, 2005, 6: e38-e45.
  • 4Luck S, Sharland M. Congenital cytomcgalovirus: new progress irJ an old disease. Paediatr Child Health, 2008, 19 : 178-184.
  • 5Lazzarotto T. The best practices for screening, monitoring, and diagnosis of cytomegalovirus disease, Part I. Clin Mic News, 2010, 32(1) :1-6.
  • 6Lazzarotto T. The best practices ibr screening, monitoring, anti diagnosis of cytomegalovirus disease, Part Ⅱ. Clin Mic News, 2010, 32(2) : 9-15.
  • 7方峰.巨细胞病毒感染//朱启镕,方峰.小儿传染病学.3版.北京:人民卫生出版社,2009:63-67.
  • 8Britt W. Manifestation of human cytomegalovirus inlection: proposed mechanism of acute and chronic diseases// Shenk TE, Stinski MF. Human cytomegalovirus. Berlin: Springer, 2008: 417-470.
  • 9Marshall BC, Koch WC. Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmaeokinetics, tbrmulations, dosing, and adverse events. Pediatr Drugs, 2009, 11 : 309-321.
  • 10Goelz R, Hihn E, Hamprecht K, et al. Effects of different CMV- inactivation-methods on growth factors in human milk. Pediatric Reseach, 2009, 65: 455-461.

共引文献193

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部